The table below shows the adverse reactions that happened in 10.0% or more of participants during the study. There were other adverse reactions, but these happened in fewer participants.

Most common adverse reactions:
Cotadutide         Placebo
Adverse reaction (out of participants) (out of participants)
Nausea                60.0% (30)               8.3% (2)
Vomiting             26.0% (13)               0.0% (0)
Reduced appetite  20.0% (10)               4.2% (1)
Diarrhea              12.0% (6)                 4.2% (1)

How has this study helped patients and researchers?

This study helped researchers learn more about the safety of cotadutide in participants with obesity and NAFLD or NASH.

Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this one study.

Other studies may provide new information or different results.

Further clinical studies with cotadutide are planned.